 Phase outpatient therapy patients advanced malignancy Twenty-six patients phase combination continuous infusion IFN patients outpatient setting maximum-tolerated dose agents outpatient therapy days days IFN consecutive weeks rest period weeks treatment Fatigue treatment-limiting toxicity serious clinical laboratory abnormalities study Patients colon cancer metastatic liver treatment patients tumors patients renal cell cancer assessable response determinations patients complete tumor regression partial objective regression patients experienced stabilization progressive disease therapy outpatient treatment setting significant activity advanced renal cell cancer